Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance
오미크론 변이체(B.1.1.529): 감염성, 백신 돌파구 및 항체 내성
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
antibodies
antibody resistance
artificial intelligence
AstraZeneca
B.1.1.529
Celltrion
Complete
complexes
contagious
coronavirus
delta variant
determined by
develop
domain
drug
Drug administration
Efficacy
experimental results
food
GlaxoSmithKline
Impact
Infectivity
likelihood
Lilly
mAb
mAbs
Mild
monoclonal antibodies
monoclonal antibody
Mutation
mutations
omicron
Panic
Protein
Quantitative analysis
RBD
Regeneron
resistance
respiratory
response
reveal
SARS-CoV-2
SARS-CoV-2 vaccine
SARS-CoV-2 variant
Structure
the SARS-CoV-2
U.S. Food and Drug Administration
university
Vaccine
Vaccines
variant
virus
[DOI] 10.1021/acs.jcim.1c01451 PMC 바로가기 [Article Type] Article
[DOI] 10.1021/acs.jcim.1c01451 PMC 바로가기 [Article Type] Article